Skip to main content

Guardian Pharmacy Services, Inc.

corporate_fare Company Profile

Guardian Pharmacy Services, Inc.

GRDN·NYSE·Trade & Services·CIK 0001802255

Guardian Pharmacy Services is a leading pharmacy services company providing technology-enabled services to residents of long-term care facilities (LTCFs). The company focuses on helping residents adhere to their drug regimens to reduce care costs and improve clinical outcomes. Guardian emphasizes individualized clinical, drug dispensing, and administration capabilities tailored for residents in historically lower acuity LTCFs, specifically assisted living facilities (ALFs) and behavioral health facilities and group homes (BHFs). Over two-thirds of Guardian's annual revenue for each of the past three years came from residents of ALFs and BHFs, with the remainder primarily from skilled nursing facilities (SNFs). As of December 31, 2025, Guardian operated 61 pharmacies, 54 of which are full-service, serving approximately 205,000 residents in approximately 8,400 LTCFs across 38 states. The company addresses challenges in ALFs and BHFs, such as residents being on various pharmacy benefit plans with distinct formularies and reimbursement processes, and ALFs often lacking staff with formal clinical training, on-site medical directors, or full-time nurses.

Guardian Pharmacy Services, Inc. (NYSE:GRDN) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 30 items for GRDN at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Director & 10% Owner Sells Over $105M in Shares at Discount in Secondary Offering
  • Guardian Pharmacy Services to Repurchase 1.83M Shares, Countering Recent Offering Overhang
  • Guardian Pharmacy Services Finalizes Secondary Offering with Non-Dilutive Structure and Loses Controlled Company Status
  • Insiders Offload $154M in Secondary Offering at Discount; Company Loses 'Controlled' Status
  • Guardian Pharmacy Services Registers Additional 900,000 Shares for Secondary Offering by Selling Stockholders

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.45B
Net Income
$49.22M
Op. Cash Flow
$100.25M
Free Cash Flow
$86.84M
Gross Profit
$292.72M
Operating Income
$72.7M
Cash & Equivalents
$65.62M
Total Debt
$0
Debt / Equity
0.00×
Net Margin
3.4%
Source: 10-K · filed 2026-03-11 · accession 0001193125-26-102172
$46.94
52-week range · as of 2026-09-28 $23.14 – $48.33
Market cap
$2.97B
Volume
526.7K (1.1× avg)
3-mo avg 488.2K
Live data · 2026-11-22 12:45 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GRDN - Filings & News (Page 2)

GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
GRDN
Mar 23, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $37.26
Real-time Price: $46.94 info
Change: +$9.68 (+26%) info
Market Cap: $2.974B info
GRDN
Mar 23, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $37.26
Real-time Price: $46.94 info
Change: +$9.68 (+26%) info
Market Cap: $2.974B info
GRDN
Mar 19, 2026, 5:37 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $34.39
Real-time Price: $46.94 info
Change: +$12.55 (+36%) info
Market Cap: $2.974B info
GRDN
Mar 19, 2026, 4:46 PM EDT
Filing Type: S-3MEF
Importance Score:
8
Price at Filing: $34.39
Real-time Price: $46.94 info
Change: +$12.55 (+36%) info
Market Cap: $2.974B info
GRDN
Mar 18, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $31.50
Real-time Price: $46.94 info
Change: +$15.44 (+49%) info
Market Cap: $2.974B info
GRDN
Mar 11, 2026, 4:41 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $33.05
Real-time Price: $46.94 info
Change: +$13.89 (+42%) info
Market Cap: $2.974B info
GRDN
Mar 11, 2026, 4:15 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $34.00
Real-time Price: $46.94 info
Change: +$12.94 (+38%) info
Market Cap: $2.974B info
GRDN
Mar 11, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.00
Real-time Price: $46.94 info
Change: +$12.94 (+38%) info
Market Cap: $2.974B info
GRDN
Jan 13, 2026, 4:41 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $31.26
Real-time Price: $46.94 info
Change: +$15.68 (+50%) info
Market Cap: $2.974B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets